Neurol. praxi. 2012;13(4):198-203

Rhabdomyolysis

doc.MUDr.Peter Špalek, PhD.
Centrum pre neuromuskulárne ochorenia, Neurologická klinika SZU, Univerzitná nemocnica Bratislava - Ružinov

Rhabdomyolysis, a syndrome of skeletal muscle breakdown with leakage of muscle contents, is frequently accompanied by myoglobinuria,

and if sufficiently severe, acute renal failure with potentially life-threatening metabolic derangements may ensue. Rhabdomyolysis

is caused by a diverse spectrum of inherited and acquired disorders affecting muscle membranes, membrane ion channels and muscle

energy supply. The commmon final pathophysiological mechanisms of all causes of rhabdomyolysis is an uncontrolled rise in free intracellular

calcium and activation of calcium-dependent proteases leading to destruction of myofibrils and lysosomal digestion of muscle

fiber contents. Recent advances in molecular genetics and muscle enzyme histochemistry may enable a specific metabolic diagnosis in

many patients with idiopathic recurrent rhabdomyolysis. Muscle weakness, myalgias and dark, tea-colored urine are the main clinical

manifestations. The most sensitive laboratory finding of muscle injury is an elevated plasma creatine kinase level. The severe life-threatening

conditions of rhabdomyolysis are associated with extreme elevations in creatine kinase, electrolyte imbalance, myoglobinuria,

acute renal failure and disseminated intravascular coagulation. The management of patients in acute phase of rhabdomyolysis is governed

by renal and metabolic consequences of myoglobinuria and requires early vigorous hydration. After the metabolic syndrome has been

corrected, triggering factors and predisposing conditions should be investigated in all cases of rhabdomyolysis.

diagnosis, management.

Keywords: rhabdomyolysis, acquired causes, inherited causes, creatine kinase, myoglobinuria, acute renal failure, clinical manifestation,

Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špalek P. Rhabdomyolysis. Neurol. praxi. 2012;13(4):198-203.
Download citation

References

  1. Agrawal S, Agrawal V, Taneja A. Hypokalemia causing rhabdomyolysis resulting in life-threatening hyperkaliemia. Pediatr Nephrol 2006; 21: 289-291. Go to original source... Go to PubMed...
  2. Barahona MJ, Mauri A, Sucunza N, Paredes R, Wägner AM. Hypothyroidism as a cause of rhabdomyolysis. Endocr J 2002; 49: 621-623. Go to original source... Go to PubMed...
  3. Bednařík J. Rabdomyolýzy. V: J. Bednařík, a kol. Nemoci kosterního svalstva. Praha; Triton 2001: 312-321.
  4. Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med 2010; 48: 749-756. Go to original source... Go to PubMed...
  5. Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. Eur J Int Med 2008; 19: 568-574. Go to original source... Go to PubMed...
  6. Chowta MN, Chowta NK. Hypothyroidism-associated rhabdomyolysis. Indian J Med Sci 2008; 62: 496-497. Go to original source... Go to PubMed...
  7. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr 2004; 16: 206-210. Go to original source... Go to PubMed...
  8. Di Mauro S, Akman O, Hays AP. Disorders of carbohydrate metabolism. In: Handbook of Clinical Neurology, Vol. 86 (3rd series). Myopathies. Eds. Mastaglia FL, Hilton-Jones D. Amsterdam, Elsevier 2007: 167-182. Go to original source...
  9. Dowling JJ, Lillis S, Amburgey K, Haiayn Z, Al-Sarraj S, Buk AJA, Wraige E, Choe G, Abbs S, Leber S, Lachlan K, Baralle D, Taylor A, Sewry C, Muntoni F, Jungbluth H. King-Denborough syndrome with and without mutations in the skeletal muscle raynodine receptor (RYR1) gene. Neuromusc Dis 2011; 21: 420-427. Go to original source... Go to PubMed...
  10. Erdogan H, Yilmaz A, Kal O, Edogan A, Arslan H. Rhabdomyolysis-induced acute renal failure associated with legionnaires´disease. Scand J Urol Nephrol 2006; 40: 345-346. Go to original source... Go to PubMed...
  11. Gurnaney H, Brown A, Litman R. Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009; 109: 1043-1048. Go to original source... Go to PubMed...
  12. Halsall PJ, Robinson RL. Malignant hyperthermia and associated conditions. In: Handbook Clin Neurol, Vol. 86 (3rd series). Myopathies. Eds. Mastaglia FL, Hilton-Jones D. Malignant hyperthermia and associated conditions. Amsterdam, Elsevier 2007: 107-124. Go to original source...
  13. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis - an overview for clinicians. Critical Care 2005; 9: 158-169. Go to original source... Go to PubMed...
  14. Khan FY. Rhabdomyolysis: a review of literature. Nether J Med 2009; 67: 272-283.
  15. Kim HW, Choi JR, Jang SJ, Chang YS, Bank BK, Park CW. Recurrent rhabdomyolysis and myoglobinuric acute renal failure in a patient with polymyositis. Nephrol Dial Transplant 2005; 20: 2255-2258. Go to original source... Go to PubMed...
  16. Laforet P, Vianey-Saban C. Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromusc Disord 2010; 20: 693-700. Go to original source... Go to PubMed...
  17. Lyoo CH, Lee MS. Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson´s disease. J Neurol 2011; 258: 1893-1894. Go to original source... Go to PubMed...
  18. Marot A, Morelle J, Chouinard VA, Jadoul M, Lambert M, Demoulin N. Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature. Acta Clin Belg 2011; 66: 134-136. Go to PubMed...
  19. Shanmugan S, Seetharam M. Viral rhabdomyolysis. South Med J 2008; 101: 1271-1272. Go to original source... Go to PubMed...
  20. Sosková M, Špalek P, Durdíková M. Akútna hypokaliemická myopatia. Neurol pre prax 2011; 12(S2): 60.
  21. Špalek P. Akútna fulminantná dermatomyozitída so sekundárnou rhabdomyolýzou a myoglobínúriou. Via practica 2010; 7(S4): 22-23. Go to original source...
  22. Špalek P, Žilinek V, Hergottová A, Yaghi A. Rhabdomyolýza - etiopatogenéza, diagnostika a liečba. Neurol pre prax 2011; 12(S2): 58-59.
  23. Špalek P. Svalové kŕče - patogenéza, diagnostika a liečba. Neurológia 2011a; 6: 61-67.
  24. Špalek P. Intravenózny imunoglobulín v liečbe dermatomyozitídy. V: Terapeutické využitie intravenóznych imunoglobulínov - príklady z praxe. Ed. P. Pružinec, a kol. Bonus Bratislava 2011: 63-66.
  25. Tunteeratum A, Witoonpanich R, Phudhichareonrat S, Eu-ahsunthornwattana J, Pingsuthiwong S, Srichan K, Sura T. Congestive heart failure with rhabdomyolysis in a manifesting female carrier of Duchenne muscular dystrophy with duplication of dystrophin gene. J Clin Neuromusc Dis 2009; 11: 49-53. Go to original source... Go to PubMed...
  26. Warren JD, Blumberg PC, Thompson PD. Rhabdomyolysis: A review. Muscle Nerve 2002; 25: 332-347. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.